Furthermore, the research team identified an overexpression of HIF-1 downstream target genes, including VEGF (Vascular Endothelial Growth Factor), Leptin (Ob), MMP-2, MMP-9, and Plasminogen Activator Inhibitor 1 (SERPINE1) in AdExos-treated BC cells. The gene discussed is HIF1A; the disease is breast cancer.